# RAPA-Keloid Study of Keloid Regression

> **NCT04049552** · EARLY_PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 4 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Rapamycin 8% Ointment
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04049552
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-24
- **Primary completion:** 2020-08-24
- **Final completion:** 2021-05-02
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04049552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04049552, "RAPA-Keloid Study of Keloid Regression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04049552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*